
Alnylam’s Amvuttra Wins FDA Approval, Challenges Pfizer in $11B Heart Drug Market
Mar 21, 2025 09:19 am UTC| Business
The U.S. Food and Drug Administration has approved Alnylam Pharmaceuticals drug Amvuttra to treat transthyretin amyloid cardiomyopathy (ATTR-CM), a rare and potentially fatal heart condition. The green light positions...

Nike Forecasts Steeper Q4 Revenue Drop Despite Strong New Sneaker Launches
Mar 21, 2025 09:19 am UTC| Business
Nike (NYSE: NKE) shares dipped nearly 5% in after-hours trading on Thursday after the company forecasted a sharper-than-expected revenue decline for the fourth quarter. CFO Matthew Friend projected a mid-teens percentage...

Elon Musk Served Summons Over SEC Lawsuit on Twitter Stock Disclosure
Mar 21, 2025 09:19 am UTC| Law Business
Elon Musk, the worlds richest man and CEO of SpaceX, has been served a summons related to a Securities and Exchange Commission (SEC) lawsuit, according to a court filing on Thursday. The summons was delivered on March 14...

Instagram Experiences Widespread Outage, Thousands Affected in the U.S.
Mar 21, 2025 09:19 am UTC| Business Technology
Instagram, owned by Meta Platforms (NASDAQ: META), suffered a major outage on Thursday evening, leaving thousands of users in the U.S. unable to access the platform. According to Downdetector, a site that tracks service...

NVIDIA CEO Jensen Huang Reconsiders Quantum Computing at GTC 2025
Mar 21, 2025 09:19 am UTC| Technology Business
At NVIDIAs GTC 2025 conference, CEO Jensen Huang took a surprising turn on his earlier skepticism toward quantum computing. Hosting two panels with leaders from 12 top quantum companies, including IonQ and D-Wave Quantum...

FedEx Cuts Full-Year Outlook as Q3 Earnings Miss Expectations
Mar 21, 2025 09:19 am UTC| Business
FedEx Corporation (NYSE: FDX) reported weaker-than-expected fiscal third-quarter earnings on Thursday, prompting a downward revision of its full-year guidance. Shares fell over 3% in after-hours trading following the...

Sanofi to Acquire Dren Bio’s Autoimmune Drug DR-0201 in $1.9B Deal
Mar 20, 2025 07:06 am UTC| Business
Sanofi (NASDAQ:SNY) has struck a major deal to acquire Dren Bios autoimmune disease treatment, DR-0201, reinforcing its expansion in the biopharmaceutical sector. The French healthcare giant announced on Thursday that it...